Clinical trial
A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
NCT01906658 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- December 31, 2014
- Enrollment
- 43 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.